The release of excellent interim results in the HER-Vaxx Phase 2 trial will speed the recruitment of the rest of the patients required to complete it. As the IDMC now says that a total of only 34 patients is enough (down from 68), only another 7 are required. This shouldn't take long now. Expect final results in the second half of calendar 21.
In the meantime Imugene is evidently moving forward on other fronts. I think we can reasonably expect a positive announcement of some sort before the end of the year - eg first patient dosed with PD1-Vaxx, or complete enrolment for HER-Vaxx Phase 2.
The next announcement that IMO would be likely to put a motor under the share price would be FDA IND clearance for CF33/ Checkvacc. I'd guess we'll hear about that within the next 3-4 months.
But DYOR!
- Forums
- ASX - By Stock
- IMU
- Imugene's Leslie Chong says positive HER-Vaxx data 'validates entire platform'
Imugene's Leslie Chong says positive HER-Vaxx data 'validates entire platform', page-242
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.6¢ |
Change
0.001(1.82%) |
Mkt cap ! $411.5M |
Open | High | Low | Value | Volume |
5.5¢ | 5.7¢ | 5.3¢ | $731.7K | 13.32M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 580359 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.7¢ | 686331 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 580359 | 0.056 |
15 | 1342805 | 0.055 |
9 | 734375 | 0.054 |
9 | 3805521 | 0.053 |
18 | 1535537 | 0.052 |
Price($) | Vol. | No. |
---|---|---|
0.057 | 686331 | 5 |
0.058 | 1249150 | 9 |
0.059 | 191714 | 3 |
0.060 | 1632398 | 13 |
0.061 | 791000 | 5 |
Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |